
Sign up to save your podcasts
Or
Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.
4.7
1818 ratings
Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.
7 Listeners
69 Listeners
1 Listeners
3 Listeners
3 Listeners
0 Listeners
6 Listeners
14 Listeners
0 Listeners
2,430 Listeners
3,332 Listeners
111,785 Listeners
1,090 Listeners
3,364 Listeners
7,928 Listeners
185 Listeners
248 Listeners
249 Listeners
366 Listeners
33 Listeners
16 Listeners
11 Listeners